Abstract
Importance
It is largely unclear whether robotic distal gastrectomy (RDG) is cost-effective for locally advanced gastric cancer (LAGC).
Objective
To evaluate the cost-effectiveness of RDG, laparoscopic distal gastrectomy (LDG), and open distal gastrectomy (ODG) for patients with LAGC.
Design, setting, and participants
Inverse probability of treatment weighting (IPTW) was used to balance baseline characteristics. A decision-analytic model was constructed to evaluate the cost-effectiveness of RDG, LDG, and ODG.
Exposures
RDG, LDG, and ODG.
Main outcomes and measures
Incremental cost-effectiveness ratio (ICER) and quality-adjusted life year (QALY).
Results
This pooled analysis of two randomized controlled trials included 449 patients: 117, 254, and 78 patients in the RDG, LDG, and ODG groups, respectively. After IPTW, RDG demonstrated its priority in terms of less blood loss, postoperative length, and complication rate (all P < 0.05). RDG also showed higher QOL with more cost, representing an ICER of $85,739.73 per QALY and $42,189.53 per QALY compared to LDG and ODG, respectively. In probabilistic sensitivity analysis, RDG achieved the best cost-effectiveness for patients with LAGC only when the willingness-to-pay threshold was > $85,739.73 per QALY, which significantly exceeded 3 times Chinese per capita GDP. Furthermore, one of the most important factors was the indirect costs of robotic surgery in terms of the cost-effectiveness of RDG compared to that of LDG or ODG.
Conclusions and relevance
Although improved short-term outcomes and QOL were seen in patients underwent RDG, the economic burden should be considered in the clinical decision-making regarding robotic surgery use for patients with LAGC. Our findings may vary in different health care settings and affordability.
Trial registration CLASS-01 trial (ClinicalTrials.gov, CT01609309) and FUGES-011 trial (ClinicalTrials.gov, NCT03313700).
Similar content being viewed by others
Data availability
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Ferlay J, Soerjomataram I, Dikshit R et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns inGLOBOCAN 2012. Int J Cancer 136(5):E359–E386. https://doi.org/10.1002/ijc.29210
Kitano S, Iso Y, Moriyama M et al (1994) Laparoscopy-assisted Billroth I gastrectomy. Surg Laparosc Endosc 4(2):146–148
Kim W, Kim HH, Han SU et al (2016) Decreased morbidity of laparoscopic distal gastrectomy compared with open distal gastrectomy for stage I gastric cancer: short-term outcomes from a multicenter randomized controlled trial (KLASS-01). Ann Surg 263(1):28–35
Hu Y, Huang C, Sun Y et al (2016) Morbidity and mortality of laparoscopic versus open D2 distal gastrectomy for advanced gastric cancer: a randomized controlled trial. J Clin Oncol 34(12):1350–1357
Kim H-H, Han S-U, Kim M-C et al (2019) Effect of laparoscopic distal gastrectomy vs open distal gastrectomy on long-term survival among patients with stage I gastric cancer. JAMA Oncol 5(4):506
Yu J, Huang C, Sun Y et al (2019) Effect of laparoscopic vs open distal gastrectomy on 3- year disease-free survival in patients with locally advanced gastric cancer: the CLASS-01 randomized clinical trial. JAMA 321(20):1983–1992
Katai H, Mizusawa J, Katayama H et al (2020) Survival outcomes after laparoscopy-assisted distal gastrectomy versus open distal gastrectomy with nodal dissection for clinical stage IA or IB gastric cancer (JCOG0912): a multicentre, non-inferiority, phase 3 randomised controlled trial. Lancet Gastroenterol Hepatol 5(2):142–151 (PMID: 31757656)
Inaki N, Etoh T, Ohyama T et al (2015) A multi-institutional, prospective, phase II feasibility study of laparoscopy-assisted distal gastrectomy with D2 lymph node dissection for locally advanced gastric cancer (JLSSG0901). World J Surg 39(11):2734–2741
Kim HH, Han SU, Kim MC et al (2019) Korean laparoendoscopic gastrointestinal surgery study (KLASS) group effect of laparoscopic distal gastrectomy vs open distal gastrectomy on long-term survival among patients with stage I gastric cancer: the KLASS-01 randomized clinical trial. JAMA Oncol 5(4):506–513. https://doi.org/10.1001/jamaoncol.2018.6727
Song J, Oh SJ, Kang WH et al (2009) Robot-assisted gastrectomy with lymph node dissection for gastric cancer. Ann Surg 249(6):927–932
Bobo Z, Xin W, Jiang L et al (2019) Robotic gastrectomy versus laparoscopic gastrectomy for gastric cancer: meta-analysis and trial sequential analysis of prospective observational studies. Surg Endosc 33(4):1033–1048
Gong S, Li X, Tian H et al (2022) Clinical efficacy and safety of robotic distal gastrectomy for gastric cancer: a systematic review and meta-analysis. Surg Endosc 36(5):2734–2748
Omori T, Yamamoto K, Hara H et al (2022) Comparison of robotic gastrectomy and laparoscopic gastrectomy for gastric cancer: a propensity score-matched analysis. Surg Endosc 36(8):6223–6234
Lee J, Kim YM, Woo Y et al (2015) Robotic distal subtotal gastrectomy with D2 lymphadenectomy for gastric cancer patients with high body mass index: comparison with conventional laparoscopic distal subtotal gastrectomy with D2 lymphadenectomy. Surg Endosc 29(11):3251–3260
Gao G, Liao H, Jiang Q, Liu D, Li T (2022) Surgical and oncological outcomes of robotic- versus laparoscopic-assisted distal gastrectomy with D2 lymphadenectomy for advanced gastric cancer: a propensity score-matched analysis of 1164 patients. World J Surg Oncol 20(1):315
Lu J, Zheng CH, Xu BB et al (2021) Assessment of robotic versus laparoscopic distal gastrectomy for gastric cancer: a randomized controlled trial. Ann Surg 273(5):858–867 (PMID: 32889876)
Association JGC (2011) Japanese classifcation of gastric carcinoma: 3rd English edition. Gastric Cancer 14:101
Amin MB, Edge S, Greene F et al (2017) AJCC cancer staging manual, 8th edn. Springer International Publishing, Cham
Japanese Gastric Cancer A (2017) Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer 20(1):1–19
Kim YW, Min JS, Yoon HM et al (2022) Laparoscopic sentinel node navigation surgery for stomach preservation in patients with early gastric cancer: a randomized clinical trial [published online ahead of print, 2022 Mar 24]. J Clin Oncol. https://doi.org/10.1200/JCO.21.02242
Austin PC (2011) An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res 46:399–424
Austin PC (2016) Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis. Stat Med 35:5642–5655
Bonnot PE, Piessen G, Kepenekian V et al (2019) Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): a propensity score analysis. J Clin Oncol 37(23):2028–2040. https://doi.org/10.1200/JCO.18.01688
Shin HJ, Son SY, Wang B, Roh CK, Hur H, Han SU (2021) Long-term comparison of robotic and laparoscopic gastrectomy for gastric cancer: a propensity score-weighted analysis of 2084 consecutive patients. Ann Surg 274(1):128–137. https://doi.org/10.1097/SLA.0000000000003845
Hu L, Gu C, Lopez M, Ji J, Wisnivesky J (2020) Estimation of causal effects of multiple treatments in observational studies with a binary outcome. Stat Methods Med Res 29(11):3218–3234. https://doi.org/10.1177/0962280220921909
Simianu VV, Gaertner WB, Kuntz K et al (2020) Cost-effectiveness evaluation of laparoscopic versus robotic minimally invasive colectomy. Ann Surg 272(2):334–341. https://doi.org/10.1097/SLA.0000000000003196
Simianu VV, Curran T, Gaertner WB et al (2021) A Cost-effectiveness evaluation of surgical approaches to proctectomy. J Gastrointest Surg 25(6):1512–1523. https://doi.org/10.1007/s11605-020-04615-5
Braithwaite RS, Meltzer DO, King JT Jr et al (2008) What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule? Med Care 46:349–356
Neumann PJ, Cohen JT, Weinstein MC (2014) Updating cost-effectiveness—the curious resilience of the $50,000-per-QALY threshold. N Engl J Med 371:796–797
Gosselin-Tardif A, Abou-Khalil M, Mata J et al (2020) Laparoscopic versus open subtotal gastrectomy for gastric adenocarcinoma: cost-effectiveness analysis. BJS Open 4(5):830–839 (PMID: 32762036)
Clavien Pierre A, Jeffrey B, de Oliveira ML et al (2009) The Clavien–Dindo classification of surgical complications: five-year experience. Ann Surg 250:187–196
Zheng-Yan Li, Yan-Bing Z, Tai-Yuan Li et al (2021) Robotic Gastrectomy versus Laparoscopic Gastrectomy for Gastric Cancer: A Multicenter Cohort Study of 5402 Patients in China. Ann Surg. https://doi.org/10.1097/SLA.0000000000005046
Bureau of Labor Statistics. Consumer price index inflation calculator. Available at: https://www.bls.gov/data/inflation_calculator.htm.
Bertram MY, Lauer JA, De Joncheere K, Edejer T, Hutubessy R, Kieny MP, Hill SR (2016) Cost-effectiveness thresholds: pros and cons. Bull World Health Organ 94(12):925–930. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153921/pdf/BLT.15.164418.pdf/
Zhou Q (2022) China’s most productive provinces and cities as per 2021 GDP statistics. China Briefing. Available from: https://www.china-briefing.com/news/chinas-2021-gdp-performance-a-look-at-major-provinces-and-cities/
Qi-Yue C, Qing Z, Zhi-Yu L et al (2021) Surgical outcomes, technical performance and surgery burden of robotic total gastrectomy for locally advanced gastric cancer a prospective study. Ann Surg. https://doi.org/10.1097/SLA.0000000000004764
Toshiyasu O, Masaki N, Keiji H et al (2021) Short-term outcomes of robotic gastrectomy vs laparoscopic gastrectomy for patients with gastric cancer: a randomized clinical trial. JAMA Surg. https://doi.org/10.1001/jamasurg.2021.3182
Kubo N, Sakurai K, Tamamori Y et al (2022) Less severe intra-abdominal infections in robotic surgery for gastric cancer compared with conventional laparoscopic surgery: a propensity score-matched analysis. Ann Surg Oncol 29(6):3922–3933. https://doi.org/10.1245/s10434-022-11410-w
Lee H-J, Hyung WJ, Yang H-K et al (2019) Short-term outcomes of a multicenter randomized controlled trial comparing laparoscopic distal gastrectomy with D2 lymphadenectomy to open distal gastrectomy for locally advanced gastric cancer (KLASS-02-RCT). Ann Surg 270(6):983–991. https://doi.org/10.1097/SLA.0000000000003217
Wang J-B, Zhong Q, Chen Q-Y et al (2019) Well-designed retrospective study versus small-sample prospective study in research based on laparoscopic and open radical distal gastrectomy for advanced gastric cancer. Surg Endosc. https://doi.org/10.1007/s00464-019-07237-4
Lu J, Wu D, Xu BB et al (2022) A matched cohort study of the failure pattern after laparoscopic and open gastrectomy for locally advanced gastric cancer: does the operative approach matter? Surg Endosc 36(1):689–700. https://doi.org/10.1007/s00464-021-08337-w
Huang C, Liu H, Hu Y et al (2022) Laparoscopic vs open distal gastrectomy for locally advanced gastric cancer: five-year outcomes from the CLASS-01 randomized clinical trial. JAMA Surg 157(1):9–17. https://doi.org/10.1001/jamasurg.2021.5104
Son SY, Hur H, Hyung WJ et al (2022) Laparoscopic vs open distal gastrectomy for locally advanced gastric cancer: 5-year outcomes of the KLASS-02 randomized clinical trial. JAMA Surg 157(10):879–886. https://doi.org/10.1001/jamasurg.2022.2749
Etoh T, Ohyama T, Sakuramoto S et al (2023) Five-year survival outcomes of laparoscopy-assisted vs open distal gastrectomy for advanced gastric cancer: the JLSSG0901 randomized clinical trial [published online ahead of print, 2023 Mar 15]. JAMA Surg. https://doi.org/10.1001/jamasurg.2023.0096
Dali C, Poming K, Shaolin T et al (2021) Cost-effectiveness evaluation of robotic-assisted thoracoscopic surgery versus open thoracotomy and video-assisted thoracoscopic surgery for operable non-small cell lung cancer. Lung Cancer 153:99–107
Ian C, Fuchs Charles S, Atsushi O et al (2019) Association of quality of life with disease characteristics and treatment outcomes in patients with advanced gastric cancer: Exploratory analysis of RAINBOW and REGARD phase III trials. Eur J Cancer 107:115–123
Maria CE, Rugo Hope S, Mayer Ingrid A et al (2021) PIK3CAPatient-reported outcomes in patients with -mutated hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer from SOLAR-1. J Clin Oncol 39:2005–2015
Young-Woo K, Hae BY, Ho YY et al (2008) Improved quality of life outcomes after laparoscopy-assisted distal gastrectomy for early gastric cancer: results of a prospective randomized clinical trial. Ann Surg 248:721–727
De Pastena M, Esposito A, Paiella S et al (2021) Cost-effectiveness and quality of life analysis of laparoscopic and robotic distal pancreatectomy: a propensity score-matched study. Surg Endosc 35(3):1420–1428 (PMID: 32240383)
Aboumohamed AA, Raza SJ, Al-Daghmin A et al (2014) Health-related quality of life outcomes after robot-assisted and open radical cystectomy using a validated bladder-specific instrument: a multi-institutional study. Urology 83(6):1300–1308 (PMID: 24746661)
Kim HJ, Choi GS, Park JS, Park SY, Yang CS, Lee HJ (2018) The impact of robotic surgery on quality of life, urinary and sexual function following total mesorectal excision for rectal cancer: a propensity score-matched analysis with laparoscopic surgery. Colorectal Dis 20(5):O103–O113 (PMID: 29460997)
Abitbol J, Lau S, Ramanakumar AV, Press JZ et al (2014) Prospective quality of life outcomes following robotic surgery in gynecologic oncology. Gynecol Oncol 134(1):144–149 (PMID: 24796633)
Uyama I, Suda K, Nakauchi M et al (2019) Clinical advantages of robotic gastrectomy for clinical stage I/II gastric cancer: a multi-institutional prospective single-arm study. Gastric Cancer 22(2):377–385. https://doi.org/10.1007/s10120-018-00906-8
Kaiser Family Foundation. Hospital adjusted expenses per inpatient day. Available at: https://www.kff.org/health-costs/state-indicator/expenses-per-inpatient-day
Bureau of Labor Statistics (2017) Usual weekly earning of wage and salary workers third quarter 2017. Available at: https://www.bls.gov/news.release/wkyeng.toc.htm.
Barbash Gabriel I, Bernard F, Glied Sherry A et al (2014) Factors associated with adoption of robotic surgical technology in US hospitals and relationship to radical prostatectomy procedure volume. Ann Surg 259:1–6
Al-Mazrou AM, Baser O, Kiran RP (2018) Propensity score-matched analysis of clinical and financial outcomes after robotic and laparoscopic colorectal resection. J Gastrointest Surg 22(6):1043–1051
Leung KL, Kwok SP, Lam SC et al (2004) Laparoscopic resection of rectosigmoid carcinoma: prospective randomised trial. Lancet 363:1187–1192
Chi-Leung C, Sik-Kwan C, Shing-Fung L et al (2021) Cost-effectiveness of Pembrolizumab as a second-line therapy for hepatocellular carcinoma. JAMA Netw Open 4:e2033761
Cadham Christopher J, Pianpian C, Jinani J et al (2021) Cost-effectiveness of smoking cessation interventions in the lung cancer screening setting: a simulation study. J Natl Cancer Inst. https://doi.org/10.1093/jnci/djab002
Hammer Mark M, Eckel Andrew L, Palazzo Lauren L et al (2021) Cost-effectiveness of treatment thresholds for subsolid pulmonary nodules in CT Lung cancer screening. Radiology. https://doi.org/10.1148/radiol.2021204418
Hagen ME, Pugin F, Chassot G et al (2012) Reducing cost of surgery by avoiding complications: the model of robotic Roux-en-Y gastric bypass. Obes Surg 22(1):52–61. https://doi.org/10.1007/s11695-011-0422-1
Acknowledgements
We thank all colleagues and nurses who provided patient care. We also thank all the family members (Chungui Ke et al.) who are supporting us. We hope that our contribution will be positive for LAGC patients.
Funding
This study was funded by Fujian Research and Training Grants for Young and Middle-aged Leaders in Healthcare.
Author information
Authors and Affiliations
Contributions
Conception/Design: JL, DW, C-MH and C-HZ. Collection and/or assembly of data: JL, DW, J-bH, B-bX, ZX, H-LZ, G-sL, JL, L-lS, J-WX, J-BW, J-XL, Q-YC, L-LC, PL, C-HZ, C-MH. Data analysis and interpretation: DW, JL, ZX, B-bX, J-bH, H-LZ, PL, C-HZ, C-MH. Manuscript writing: DW, JL, J-bH, C-MH and C-HZ. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Disclosures
Jun Lu, Dong Wu, Jiao-bao Huang, Jia Lin, Bin-bin Xu, Zhen Xue, Hua-Long Zheng, Guo-sheng Lin, Li-li Shen, Ping Li, Jia-Bin Wang, Jian-Xian Lin, Qi-Yue Chen, Long-Long Cao, Jian-Wei Xie, Chao-Hui Zheng, and Chang-Ming Huang have no conflicts of interest or financial ties to disclose.
Ethical approval
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions.
Consent for publication
This article doesn’t report an individual participant's data in any form.
Informed consent
Informed consent or substitute for it was obtained from all patients for being included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Lu, J., Wu, D., Huang, Jb. et al. Comparison of robotic versus laparoscopic versus open distal gastrectomy for locally advanced gastric cancer: a prospective trial-based economic evaluation. Surg Endosc 37, 7472–7485 (2023). https://doi.org/10.1007/s00464-023-10147-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-023-10147-1